Index.php

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban generic name) and suffered critical bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably secure for use - and failure to perform so may possibly be grounds for compensation. Our lawyers are functioning challenging to get these hurt by the drug the compensation they are entitled to.

Although bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is more dangerous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, sufferers may be at danger for irreversible bleeding issues, including life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a loved one suffered a significant bleeding occasion right after taking Xarelto, you may have legal recourse. For a lot more data, contact us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. Furthermore, they may be searching for punitive damages, which are generally awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.

Visit this page for far more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.